Transcode Therapeutics RNAZ Peer Comparison

NASDAQ RNAZ
$1.76 -0.01 (-0.84%)
As of: Sep 10, 2026 · 10:13 AM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 207.59 Bn 23.74 5.45 193.60 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 178.73 Bn -61.74 5.87 175.55 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 131.17 Bn 29.78 10.42 123.32 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 81.73 Bn 18.88 5.26 73.73 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 61.01 Bn 35.57 11.67 55.82 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 53.40 Bn -16.95 23.97 48.27 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 33.49 Bn 43.23 6.97 30.18 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 31.64 Bn 37.90 3.15 30.35 Bn
9 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 29.66 Bn -19.98 2,715.04 29.66 Bn
10 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.74 Bn -31.69 24.38 26.58 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 23.35 Bn -13.70 7.55 9.70 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 18.23 11.15 14.86 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.57 Bn -48.81 12.13 14.73 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.61 Bn -21.11 20.48 13.89 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.36 Bn — — 12.67 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.60 Bn 30.46 7.57 12.37 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.49 Bn 171.13 3.67 11.61 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 11.90 Bn -43.73 17.78 10.30 Bn
19 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.86 Bn -25.86 — 9.11 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.52 Bn 86.24 33.77 9.52 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.16 Bn -43.17 10.48 7.11 Bn
24 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
25 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.12 Bn -8.19 49.01 7.77 Bn
26 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn -14.57 — 7.84 Bn
27 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.75 Bn 17.53 9.69 7.06 Bn
28 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.44 Bn -41.56 — 7.44 Bn
30 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.37 Bn -18.26 — 7.37 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -33.13 29.03 6.63 Bn
32 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.37 Bn -28.43 1,023.05 6.37 Bn
33 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.34 Bn -707.43 4,551.55 6.34 Bn
34 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.21 Bn -7.22 10.05 5.77 Bn
35 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.97 Bn 74.02 7.10 5.44 Bn
36 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -16.10 — 5.84 Bn
37 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 29.42 19.97 4.44 Bn
38 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn -15.66 — 5.79 Bn
39 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn — — 4.05 Bn
40 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.73 Bn -32.54 1,141.06 5.55 Bn
41 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.60 Bn 14.63 5.55 3.37 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.21 Bn -18.15 — 5.21 Bn
43 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.80 Bn -21.91 — 4.80 Bn
44 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.87 1,116.40 4.02 Bn
45 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.01 Bn — — 3.61 Bn
46 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
47 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -13.27 366.50 3.79 Bn
48 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.76 Bn -7.02 — 3.76 Bn
49 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -35.05 66.66 2.57 Bn
50 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -29.40 — 3.57 Bn
51 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.51 Bn -15.94 14.99 2.68 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.43 Bn -7.46 29.34 2.73 Bn
53 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.33 Bn -20.21 50.29 3.33 Bn
54 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.07 Bn 107.75 6.62 2.83 Bn
55 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn -5.82 — 3.00 Bn
56 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.98 Bn -9.70 18,878.66 2.98 Bn
57 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.98 Bn -28.53 — 2.98 Bn
58 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -14.54 — 2.93 Bn
59 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -10.81 593.06 2.40 Bn
60 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.84 Bn -8.33 77.36 2.40 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -14.38 6.02 2.00 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -79.73 — 2.59 Bn
63 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.49 Bn -8.23 47.84 2.49 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
65 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 44.17 1.73 Bn
66 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
67 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -5.83 32.76 2.33 Bn
68 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn -11.33 — 1.88 Bn
69 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.20 Bn -35.25 11.63 2.09 Bn
70 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 12.97 4.21 2.02 Bn
71 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.17 0.33 0.60 Bn
72 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -8.58 — 2.08 Bn
73 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.36 3.85 1.71 Bn
74 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -14.96 102.61 2.05 Bn
75 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.02 Bn -4.90 20.50 2.02 Bn
76 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -4.78 1,987.41 1.99 Bn
77 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -13.12 52.98 1.70 Bn
78 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -9.44 71.07 1.67 Bn
79 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -4.89 — 1.93 Bn
80 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.90 Bn -3.23 — 1.63 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -11.22 17.46 1.45 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn -7.10 5.89 1.79 Bn
83 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -13.30 1,365.01 1.77 Bn
84 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn -95.67 4.02 0.85 Bn
85 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
86 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn -123.73 17.47 1.73 Bn
87 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -3.29 31.11 1.16 Bn
88 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -9.35 6.72 1.15 Bn
89 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -6.36 — 1.13 Bn
90 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -26.83 — 1.31 Bn
91 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.37 525.90 1.60 Bn
92 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -66.10 7.93 1.29 Bn
93 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -188.43 916.54 1.58 Bn
94 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
95 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -8.49 — 1.57 Bn
96 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -10.29 — 1.53 Bn
97 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -6.11 3.66 0.79 Bn
98 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -14.10 74.75 1.49 Bn
99 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -9.11 20.12 1.20 Bn
100 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -3.16 2.04 1.17 Bn
101 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.35 50.11 0.81 Bn
102 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -17.13 — 1.43 Bn
103 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -8.61 — 1.41 Bn
104 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn 79.11 35.14 1.35 Bn
105 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -9.66 — 1.35 Bn
106 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -4.52 — 1.34 Bn
107 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -8.54 — 1.34 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -11.05 857.46 1.14 Bn
109 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.29 Bn -6.29 — 1.29 Bn
110 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -5.23 152.12 0.76 Bn
111 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -1.35 — 1.24 Bn
112 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.20 Bn -25.11 — 0.98 Bn
113 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -27.26 3.02 1.08 Bn
114 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -11.55 49.38 1.19 Bn
115 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.54 — 1.16 Bn
116 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.11 Bn -19.26 — 1.11 Bn
117 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.65 5.58 0.92 Bn
118 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -3.73 — 0.45 Bn
119 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -118.02 — 0.97 Bn
120 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -4.76 14.73 0.59 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -68.42 — 0.90 Bn
122 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -13.83 3.82 0.63 Bn
123 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -16.46 2.03 0.63 Bn
124 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.81 8.44 0.49 Bn
125 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.70 3.15 0.78 Bn
126 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn -4.16 — 0.85 Bn
127 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 816.31 0.82 Bn
128 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -9.80 94.91 0.78 Bn
129 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.76 — 0.78 Bn
130 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -9.93 41.15 0.42 Bn
131 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -121.07 2.26 0.59 Bn
132 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn -6.12 — 0.71 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -6.12 — 0.60 Bn
134 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.66 Bn 2.96 1.68 0.58 Bn
135 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.14 1,020.00 0.56 Bn
136 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.32 — 0.61 Bn
137 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.72 584.05 0.44 Bn
138 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -12.52 — 0.60 Bn
139 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -339,460.11 — 0.60 Bn
140 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 471.72 7.84 0.27 Bn
141 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.74 3.41 0.43 Bn
142 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 60.76 1.78 0.00 Bn
143 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.32 — 0.56 Bn
144 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -6.44 — 0.55 Bn
145 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.62 13.38 0.46 Bn
146 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -4.45 — 0.51 Bn
147 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.43 22.33 0.22 Bn
148 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
149 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -10.91 8.79 0.19 Bn
150 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.77 — 0.45 Bn
151 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 14.92 2.42 0.39 Bn
152 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.45 2.00 0.37 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.56 — 0.46 Bn
154 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -2.27 — 0.23 Bn
155 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -5.46 — 0.45 Bn
156 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -15.23 — 0.44 Bn
157 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.35 12.57 0.19 Bn
158 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.07 — 0.42 Bn
159 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.89 — 0.40 Bn
160 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.24 38.47 0.40 Bn
161 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.16 13.48 0.20 Bn
162 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.25 — 0.24 Bn
163 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.11 38.88 0.19 Bn
164 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -5.99 5.79 0.19 Bn
165 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -1.16 128.62 0.18 Bn
167 DMAC DiaMedica Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -10.65 — 0.35 Bn
168 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -2.91 — 0.35 Bn
169 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -4.19 — 0.33 Bn
170 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -6.50 — 0.33 Bn
171 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.89 8.75 0.25 Bn
172 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.82 — 0.32 Bn
173 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.97 99.70 0.31 Bn
174 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 64.31 — 0.19 Bn
175 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.64 3.33 0.14 Bn
176 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -16.01 — 0.29 Bn
177 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 3.12 2.16 0.29 Bn
178 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.71 60.37 0.28 Bn
179 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.12 12.51 0.28 Bn
180 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.04 — 0.28 Bn
181 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.43 4.45 0.27 Bn
182 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.33 — 0.26 Bn
183 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -16.02 1.54 0.14 Bn
184 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.08 — 0.26 Bn
185 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.09 60.46 0.25 Bn
186 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.12 — 0.25 Bn
187 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.98 4.47 0.09 Bn
188 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.39 — 0.25 Bn
189 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -17.60 — 0.13 Bn
190 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.79 20.10 0.23 Bn
191 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.52 3.10 0.14 Bn
192 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.61 16.49 0.06 Bn
193 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.72 94.31 0.11 Bn
194 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -10.00 — 0.22 Bn
195 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.13 — 0.22 Bn
196 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.45 6.72 -0.04 Bn
197 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.33 — 0.22 Bn
198 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.27 15.56 0.18 Bn
199 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 10.16 2.67 0.17 Bn
200 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.97 — 0.21 Bn
201 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.30 — 0.18 Bn
202 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -4.15 9.53 0.07 Bn
203 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.53 3.97 0.10 Bn
204 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.92 — 0.20 Bn
205 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 1.14 — 0.19 Bn
206 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -13.14 32.66 0.19 Bn
207 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.28 2.50 -0.03 Bn
208 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
209 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.81 8.15 0.17 Bn
210 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.39 — 0.18 Bn
211 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.08 60.09 0.17 Bn
212 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.54 2.71 0.04 Bn
213 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.70 — -0.01 Bn
214 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -10.95 — 0.15 Bn
215 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.81 32.39 0.16 Bn
216 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.42 190.84 0.16 Bn
217 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -116.03 — 0.15 Bn
218 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -4.95 12.95 0.12 Bn
219 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.96 — 0.15 Bn
220 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
221 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.07 — 0.14 Bn
222 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -9.63 — 0.13 Bn
223 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,762.63 -0.05 Bn
224 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.83 — 0.14 Bn
225 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.23 — 0.13 Bn
226 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.91 1,289.41 0.13 Bn
227 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -6.09 37.36 0.10 Bn
228 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.75 129.38 0.13 Bn
229 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.95 — 0.07 Bn
230 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.78 41.63 0.12 Bn
231 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -3.44 — 0.12 Bn
232 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -2.41 — 0.00 Bn
233 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -6.55 — 0.11 Bn
234 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.82 13.41 0.06 Bn
235 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.38 — 0.11 Bn
236 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn — — -0.06 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -10.01 — 0.09 Bn
238 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -3.24 — 0.10 Bn
239 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -2.13 60.89 0.10 Bn
240 TLPH Talphera, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -6.42 90,624.73 0.09 Bn
241 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.92 — 0.09 Bn
242 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.48 — 0.08 Bn
243 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.12 139.00 0.09 Bn
244 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
245 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.72 — 0.08 Bn
246 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.13 — 0.08 Bn
247 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 9.91 1.20 -0.11 Bn
248 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.73 — 0.08 Bn
249 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
250 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -3.02 — 0.05 Bn
251 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -4.03 — 0.07 Bn
252 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 — 0.07 Bn
253 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.48 — 0.07 Bn
254 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.72 122.14 0.07 Bn
255 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 11.56 1.42 0.02 Bn
256 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.85 — 0.07 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.59 — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -6.90 0.41 0.02 Bn
259 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.81 15.26 0.03 Bn
260 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.14 2.95 -0.06 Bn
261 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -2.89 1,552.93 0.05 Bn
262 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.08 — 0.05 Bn
263 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.29 — 0.05 Bn
264 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.40 — 0.05 Bn
265 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -6.38 — 0.04 Bn
266 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.60 26.34 0.05 Bn
267 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.76 3.78 0.05 Bn
268 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.40 5.09 0.05 Bn
269 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.42 2.29 0.05 Bn
270 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
271 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.98 — 0.04 Bn
272 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -4.40 — 0.04 Bn
273 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.67 294.15 -0.01 Bn
274 ALP Alpha Compute Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.02 0.19 0.04 Bn
275 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.45 315.35 0.02 Bn
276 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.04 — 0.02 Bn
277 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.57 1.15 0.04 Bn
278 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.03 79.26 0.04 Bn
279 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.63 — 0.04 Bn
280 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.67 — 0.03 Bn
281 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.72 4.79 0.03 Bn
282 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.75 — 0.03 Bn
283 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
284 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.09 0.93 0.02 Bn
285 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.16 4.23 0.03 Bn
286 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
287 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
288 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.34 38.21 0.03 Bn
289 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.26 — 0.03 Bn
290 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
291 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
292 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.44 — 0.03 Bn
293 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.65 — 0.03 Bn
294 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
295 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.30 869.19 0.02 Bn
296 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
297 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.49 — 0.02 Bn
298 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.71 — 0.02 Bn
299 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.14 261.63 0.02 Bn
300 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.10 — 0.02 Bn